The global postpartum hemorrhage (PPH) treatment devices market is marked by the presence of several players. The vendor landscape of the market is thus fragmented. According to Transparency Market Research (TMR), key players in the market are currently spending in promotional events to counter conventional PPH treatment methods. This, however, increases operational cost of manufacturing PPH devices, whereas it is imperative for players to keep their product prices low for penetrating into emerging markets.
As per TMR, the internal competition in the market is not likely to subside in the future. It is expected to remain highly competitive over the forthcoming years as the PPH market witnesses the entry of international players such as 3rd Stone Design, Inc., Bactiguard AB, Cook Medical, Inc., C. R. Bard, Inc., and others
The global postpartum hemorrhage treatment devices market stood at US$604.4 mn in 2014. Exhibiting a CAGR of 4.90%, the market is expected to reach US$926.1 mn by the end of 2023.
Escalating Cases of Pregnancy Related Complications Make Affordable PPH Treatment Devices Indispensable
The high prevalence of PPH is expected to fuel demand for advanced PPH treatment devices worldwide. In the last few years death in women due to pregnancy related complications has surged significantly. According to the United States Agency for International Development (USAID) and the World Bank, over 99% of maternal deaths occur in developing nations where affordable healthcare and services of skilled professionals are not easily available in remote locations.
“Companies manufacturing PPH treatment devices are creating marketing strategies to capitalize on the untapped opportunities in developing countries,” said a lead TMR analyst. This is expected to be a key driver of demand for PPH treatment devices. “The market will also gain from planned government initiatives and training aimed at ensuring remote areas access to affordable and quality healthcare services,” he added. Besides these, escalating risk factors associated with pregnancy and PPH will impel organizations to focus on production of effective devices for PPH treatment.
Lack of Awareness Inhibits PPH Treatment Device Manufacturers Entry in Developing Economies
PPH treatment devices are found in the market since the past two decades. However, a large section of people residing in developing and less developed countries lack awareness about the availability of such solutions. This is a key factor dampening the market’s growth in countries across Asia Pacific, the Middle East, and sub-Saharan Africa to an extent.
The market is also witnessing low level of acceptance for novel of unconventional PPH treatment devices. Furthermore, lack of skilled professionals also inhibits the widespread adoption of advanced PPH treatment devices across developing nations.
Nevertheless, companies are focusing on developing their existing distribution channels to spread their business across developing and less developed countries. Additionally, they are making efforts to promote awareness about the availability of these solutions. This is expected to created growth opportunities for the market in the forthcoming years.
Regionally, North America dominated the market in 2014, accounting for over 36.1% of the market based on value. Increased access to healthcare and the availability of advanced medical devices are the key factors driving the PPH treatment devices market in North America.
By products the market was led by the uterine balloon tamponade segment in 2014. Due to commercial availability, high effectiveness, and ease of use the products offer, the uterine balloon tamponade segment is expected to rise at 4.9% CAGR between 2015 and 2023.
This review is based on a TMR report, titled “Postpartum Hemorrhage (PPH) Treatment Devices Market - Global Industry Analysis, Size, Growth, Trends and Forecast 2015 - 2023.”
- Holding over 36.1% of the global market in terms of value, the North America PPH treatment devices emerged as dominant regional segment in 2014.
- Commercial availability and high effectiveness offered by uterine balloon tamponade to boost the segment at 4.9% CAGR from 2015 to 2023.
- Low acceptance for unconventional PPH treatment devices hinders the market’s growth across less developed nations.
The report segments the global postpartum hemorrhage treatment devices market as:
Postpartum Hemorrhage (PPH) Treatment Devices Market, by Products
- Non-pneumatic Anti-shock Garment (NASG)
- Uniject Prefilled Injection System
- Uterine Balloon Tamponade
- Foley Catheters
- Condom Catheters
Postpartum Hemorrhage (PPH) Treatment Devices Market, by Geography
- North America
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Latin America (LATAM)
- Middle East & North Africa (MENA)
- Rest of the World
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453